Annual EBIT
-$2.07 M
+$3.40 M+62.10%
September 1, 2024
Summary
- As of February 7, 2025, DRUG annual earnings before interest & taxes is -$2.07 million, with the most recent change of +$3.40 million (+62.10%) on September 1, 2024.
- During the last 3 years, DRUG annual EBIT has risen by +$4.88 million (+70.15%).
- DRUG annual EBIT is now -487.32% below its all-time high of -$353.20 thousand, reached on September 30, 2020.
Performance
DRUG EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$579.90 K
-$751.40 K-438.13%
September 1, 2024
Summary
- As of February 7, 2025, DRUG quarterly earnings before interest & taxes is -$579.90 thousand, with the most recent change of -$751.40 thousand (-438.13%) on September 1, 2024.
- Over the past year, DRUG quarterly EBIT has increased by +$668.10 thousand (+53.53%).
- DRUG quarterly EBIT is now -438.13% below its all-time high of $171.50 thousand, reached on June 1, 2024.
Performance
DRUG Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$2.07 M
+$601.80 K+22.52%
September 1, 2024
Summary
- As of February 7, 2025, DRUG TTM earnings before interest & taxes is -$2.07 million, with the most recent change of +$601.80 thousand (+22.52%) on September 1, 2024.
- Over the past year, DRUG TTM EBIT has increased by +$2.95 million (+58.80%).
- DRUG TTM EBIT is now -8598.32% below its all-time high of -$23.80 thousand, reached on December 31, 2019.
Performance
DRUG TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DRUG EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.1% | +53.5% | +58.8% |
| 3 y3 years | +70.2% | +53.5% | +58.8% |
| 5 y5 years | -487.3% | +53.5% | +58.8% |
DRUG EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.3% | -438.1% | +84.8% | at high | +83.7% |
| 5 y | 5-year | -487.3% | +82.3% | -438.1% | +84.8% | -8598.3% | +83.7% |
| alltime | all time | -487.3% | +82.3% | -438.1% | +84.8% | -8598.3% | +83.7% |
Bright Minds Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$2.07 M(-62.1%) | -$579.90 K(-438.1%) | -$2.07 M(-22.5%) |
| Jun 2024 | - | $171.50 K(-141.4%) | -$2.67 M(-31.8%) |
| Mar 2024 | - | -$413.80 K(-66.8%) | -$3.92 M(-22.0%) |
| Dec 2023 | - | -$1.25 M(+5.6%) | -$5.02 M(-8.1%) |
| Sep 2023 | -$5.47 M(-53.3%) | -$1.18 M(+9.8%) | -$5.47 M(-17.1%) |
| Jun 2023 | - | -$1.08 M(-29.1%) | -$6.59 M(-13.3%) |
| Mar 2023 | - | -$1.52 M(-10.3%) | -$7.60 M(-21.0%) |
| Dec 2022 | - | -$1.69 M(-26.6%) | -$9.61 M(-18.2%) |
| Sep 2022 | -$11.72 M | -$2.31 M(+10.7%) | -$11.75 M(-0.4%) |
| Jun 2022 | - | -$2.08 M(-41.0%) | -$11.80 M(-7.0%) |
| Mar 2022 | - | -$3.53 M(-7.7%) | -$12.69 M(+22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$3.83 M(+62.5%) | -$10.38 M(+47.7%) |
| Sep 2021 | -$6.95 M(+1867.6%) | - | - |
| Sep 2021 | - | -$2.36 M(-20.7%) | -$7.03 M(+41.4%) |
| Jun 2021 | - | -$2.97 M(+142.1%) | -$4.97 M(+145.1%) |
| Mar 2021 | - | -$1.23 M(+159.0%) | -$2.03 M(+151.8%) |
| Dec 2020 | - | -$473.60 K(+59.0%) | -$805.10 K(+126.6%) |
| Sep 2020 | -$353.20 K | - | - |
| Sep 2020 | - | -$297.90 K(+927.2%) | -$355.30 K(+519.0%) |
| Jun 2020 | - | -$29.00 K(+530.4%) | -$57.40 K(+102.1%) |
| Mar 2020 | - | -$4600.00(-80.7%) | -$28.40 K(+19.3%) |
| Dec 2019 | - | -$23.80 K | -$23.80 K |
FAQ
- What is Bright Minds Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Bright Minds Biosciences?
- What is Bright Minds Biosciences annual EBIT year-on-year change?
- What is Bright Minds Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly EBIT year-on-year change?
- What is Bright Minds Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Bright Minds Biosciences?
- What is Bright Minds Biosciences TTM EBIT year-on-year change?
What is Bright Minds Biosciences annual earnings before interest & taxes?
The current annual EBIT of DRUG is -$2.07 M
What is the all time high annual EBIT for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual earnings before interest & taxes is -$353.20 K
What is Bright Minds Biosciences annual EBIT year-on-year change?
Over the past year, DRUG annual earnings before interest & taxes has changed by +$3.40 M (+62.10%)
What is Bright Minds Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of DRUG is -$579.90 K
What is the all time high quarterly EBIT for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly earnings before interest & taxes is $171.50 K
What is Bright Minds Biosciences quarterly EBIT year-on-year change?
Over the past year, DRUG quarterly earnings before interest & taxes has changed by +$668.10 K (+53.53%)
What is Bright Minds Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of DRUG is -$2.07 M
What is the all time high TTM EBIT for Bright Minds Biosciences?
Bright Minds Biosciences all-time high TTM earnings before interest & taxes is -$23.80 K
What is Bright Minds Biosciences TTM EBIT year-on-year change?
Over the past year, DRUG TTM earnings before interest & taxes has changed by +$2.95 M (+58.80%)